| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/31/2006 | EP1660511A2 Novel tricyclic nucleosides or nucleotides as therapeutic agents |
| 05/31/2006 | EP1660495A1 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| 05/31/2006 | EP1660488A1 Novel antimicrobial aryloxazolidinone compounds |
| 05/31/2006 | EP1660486A1 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 05/31/2006 | EP1660475A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660467A2 Aminofurazan compounds as protein kinase inhibitors |
| 05/31/2006 | EP1660439A2 Aryl and heteroaryl compounds, compositions, and methods of use |
| 05/31/2006 | EP1660134A2 Conjugates of hydroxyalkyl starch and g-csf |
| 05/31/2006 | EP1660133A1 Targeted delivery of anti-viral compounds through hemoglobin bioconjugation |
| 05/31/2006 | EP1660121A2 Live attenuated bacterial vaccine |
| 05/31/2006 | EP1660120A1 Live attenuated aldolase-negative bacterial vaccine |
| 05/31/2006 | EP1660116A1 Method of treating viral infections |
| 05/31/2006 | EP1660085A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660078A1 Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions. |
| 05/31/2006 | EP1660068A1 Composition for treatment of tinea pedis and method of use |
| 05/31/2006 | EP1660061A1 Use of n-chlorotaurine for treatment of oozing tissue deficiencies |
| 05/31/2006 | EP1660059A1 Glycyrrhizin or derivatives thereof for treating or preventing severe acute respiratory syndrome (sars) |
| 05/31/2006 | EP1660044A2 Composition comprising a zeolite compound for treatment of diseases |
| 05/31/2006 | EP1585753B1 Novel semisynthetic macrolide antibiotics of the azalide series |
| 05/31/2006 | EP1420824B1 Sulfonated chlorines as photosensitizer |
| 05/31/2006 | EP1357924A4 Antiviral composition made from medicinal plants for combating hiv/aids |
| 05/31/2006 | EP1352061B1 Method for inhibiting the expression of a target gene |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1333845A4 Treatment of t cell disorders |
| 05/31/2006 | EP1328282B1 Efficient method for producing compositions enriched in anthocyanins |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1272223B1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 05/31/2006 | EP1270570B1 Amide compounds and use thereof |
| 05/31/2006 | EP1263467B1 Paste formulations comprising silica |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1212084B1 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 05/31/2006 | EP1175489B1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same |
| 05/31/2006 | EP1165110B1 Antagonists of hmg1 for treating inflammatory conditions |
| 05/31/2006 | EP1165073B1 Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP1108014B1 Ehrlichia canis protein |
| 05/31/2006 | EP0891426B1 Human bikunin |
| 05/31/2006 | EP0861321B1 Phosphopantetheinyl transferases and uses thereof |
| 05/31/2006 | EP0757717B1 Papillomavirus vaccines |
| 05/31/2006 | CN1780919A Methods and products based on oligomerization of stress proteins |
| 05/31/2006 | CN1780916A Chicken RNA polymerisate I promoter and the use thereof |
| 05/31/2006 | CN1780907A Anti-CCR5 antibody |
| 05/31/2006 | CN1780846A Bifunctional heterocyclic compounds and methods of making and using the same |
| 05/31/2006 | CN1780842A Crystals of quinolinecarboxylic acid derivative solvate. |
| 05/31/2006 | CN1778967A Polymeric amide-amine dendritic compound with combination of trans-activated protein and trans-activated response squence RNA against HIV-1 |
| 05/31/2006 | CN1778916A Polypeptide with Beta-lactamase inhibiting activity and its coded DNA |
| 05/31/2006 | CN1778824A Multiple homogeneous tremella polysaccharide, its extraction and medicinal composition with this compound as active components |
| 05/31/2006 | CN1778817A Protein and sugar binding protein with anti-HIV activity |
| 05/31/2006 | CN1778816A Human cell surface membrane molecule and use thereof |
| 05/31/2006 | CN1778812A Nolvac viral coat protein with recombinant rod virus expression and its preparation |
| 05/31/2006 | CN1778807A Production of Rhizoma Picrorhizae glucoside II monomer and its drug form for treating hepatitis B |
| 05/31/2006 | CN1778379A Compound pearl grass oral liquid |
| 05/31/2006 | CN1778372A Sprinkling agent for preventing influenza and its formulation thereof |
| 05/31/2006 | CN1778351A Medicine composition for treating hepatitis B and chronic hepatitis |
| 05/31/2006 | CN1778329A Medicine for treating hydrophobia and its process thereof |
| 05/31/2006 | CN1778317A Antibiotic companion for degradating bacterial drug resistance |
| 05/31/2006 | CN1778316A Degradation of bacterial drug resistance by composite microbial preparation |
| 05/31/2006 | CN1778315A Eijknisia flower honey and oral liquid |
| 05/31/2006 | CN1778313A Medicine for preventing skin superficial fungalinfection and female genital infection |
| 05/31/2006 | CN1778310A Use of rhubard and rhubard-polysaccharide in anti-HIV |
| 05/31/2006 | CN1778308A Use of picrorrhiza glycoside II in preparation of medicine for treating hepatitis B |
| 05/31/2006 | CN1778307A Clarithromycin soft capsule and its preparation |
| 05/31/2006 | CN1778295A Medical use for silybum or its salt |
| 05/31/2006 | CN1257976C Improved vaccines |
| 05/31/2006 | CN1257973C Broad spectrum infectious chicken blader disease virus vaccine |
| 05/31/2006 | CN1257969C Polygonum capilalum extract , its preparation method and use |
| 05/31/2006 | CN1257912C Beta-L-2-deoxy-nucleosides for the treatment of hepatitis B |
| 05/31/2006 | CN1257905C Compounds for inhibiting the release of inflammatory cytokines |
| 05/31/2006 | CN1257903C Quinic compound containing quaternary ammonium group and its preparation and medicine use |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257745C Chinese medicinal composition for treating typhoid |
| 05/31/2006 | CN1257718C Chinese traditional medicine composition and its preparation and quality control method thereof |
| 05/31/2006 | CN1257717C Medicine for treating pertinacious porking diarrhea and its preparation method |
| 05/31/2006 | CN1257712C Photodynamic porphyrin antimicrobial agents |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053207 L-ribo-LNA analogues |
| 05/30/2006 | US7053192 Crystal forms of azithromycin |
| 05/30/2006 | US7053185 contacting alpha-lactalbumin (in molten globule-like state) with fatty acids and lipids found in a milk fraction containing casein obtained from humans; antibacterial agents; anticancer agents |
| 05/30/2006 | US7053179 Inhibits hiv infection of cells |
| 05/30/2006 | US7053175 Delta -Z-TrpGlyCys- Theta -CysTyrThrSer- Omega, ( Delta represents a biotinyl radical, a biocytinyl radical, a hydrogen atom, an acetyl (CH3CO ) radical, an aliphatic chain which may contain one or two thiol, aldehyde or amine functional groups, and Z= a peptide sequence) |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053111 Autoimmune disease; organ transplanting; controlling cell proliferation, cell differentiation |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053061 Vegetable oil phase containing dispersed Amphotercin B; water phase containing dissolved glycerin, mannitol, or dextrose tonicity modifiers; emulsifier such as natural phosphatides |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7052909 activation of natural killer T-lymphocytes(NKT) using phosphatidylinositol mannoside(PIM); prophylaxis of skin disorders, cancers or tuberculosis |
| 05/30/2006 | US7052906 Synthetic transmembrane components |
| 05/30/2006 | US7052896 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 05/30/2006 | US7052860 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/30/2006 | US7052714 Ophthalmic adhesive preparations for percutaneous adsorption |
| 05/30/2006 | US7052701 Inactivated influenza virus vaccine for nasal or oral application |
| 05/30/2006 | US7052699 Immunogenic composition |
| 05/30/2006 | US7052689 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |